Main Line Fertility Clinic P.C.April 8, 2019

FDA 483 - Main Line Fertility Clinic P.C. - April 08, 2019

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Main Line Fertility Clinic P.C.

Record Details

Regional Women's Health Group LLC in Abington, PA, was cited for deficiencies in its human tissue reproductive establishment. The inspection revealed inadequate screening of oocyte donors for communicable disease agents, specifically the Zika Virus, by failing to assess all relevant risk factors. Additionally, issues were noted with HCT/P record-keeping, including the improper inclusion of anonymous donor names and the absence of required laboratory certification statements for communicable disease testing.

Company: Main Line Fertility Clinic P.C.
Inspection Date: April 8, 2019
Product Type: Biologics
Office: Philadelphia District Office
Person: Nikisha Rolden

Open in Dashboard

ID · 346eb3d5-336f-4e21-8e1e-a0e01e904c8e